'Emerging' Biomarker May Predict MCI Years Before Symptoms :

Measuring levels of synaptic protein NPTX2 in cognitively normal adults may help predict onset of mild cognitive impairment years before symptoms emerge.

Related Keywords

Johns Hopkins University , Maryland , United States , Baltimore , Anja Soldan , Christopher Weber , Alzheimer Association , Johns Hopkins University School Of Medicine , Johns Hopkins University School , Medscape Medical , Cautionary Notes , Medscape Medical News , Mci , Mild Cognitive Impairment , Biomarker , Iological Marker , Cognitive Impairment , Impairment , Alzheimers Disease , Lzheimer Disease , Csf , Dementia , Brain , Blood , Genetics , Genomics , Genomic Medicine , Edicine Genomic , Amyloid Beta , Cognition , Cox , Yclooxygenase , Memory , Neurodegenerative Disease , Nerve Cell ,